Insmed Beats Stock-Drop Suit Over Lung Disease Drug
By Jeannie O'Sullivan · February 16, 2018, 8:50 PM EST
A New Jersey federal judge on Thursday tossed a proposed class action alleging that Insmed Inc. misled investors over the likelihood that a lung disease drug would gain market approval in...
To view the full article, register now.